IgE-mediated asthma and rhinitis I: A role of allergen exposure?

被引:32
作者
Nielsen, GD
Hansen, JS
Lund, RM
Bergqvist, M
Larsen, ST
Clausen, SK
Thygesen, P
Poulsen, OM
机构
[1] Natl Inst Occupat Hlth, DK-2100 Copenhagen O, Denmark
[2] Royal Danish Sch Pharm, DK-2100 Copenhagen O, Denmark
来源
PHARMACOLOGY & TOXICOLOGY | 2002年 / 90卷 / 05期
关键词
D O I
10.1034/j.1600-0773.2002.900502.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Exposures to airborne protein antigens, aeroallergens, may cause sensitization with production of Th2-dependent antibodies, including IgE. The IgE antibodies and associated cellular responses are responsible for the allergic airway diseases, allergic rhinitis and allergic asthma, which are increasing in societies with Western life style. Aeroallergens may have different potential to sensitize exposed subjects. Thus, there are only a limited number of important groups of aeroallergens, which are those from house dust mites, cockroaches, pets, pollens, and moulds, Allergy follows to a certain extent the pharmacological/toxicological paradigm of dose-response relationship. Unlike effects of pharmacologically and toxicologically active substances, allergens elicit their adverse effects in a two-stage process. In the first stage the immunologically naive individual is sensitized to the allergen. In the second stage renewed exposure to the allergen elicits the disease response. Also, high concentrations of aeroallergens may induce immunological tolerance. The scientific literature suggests that many environmental factors contribute to the increase in sensitization and development of airway allergies, Nevertheless, the dose-response relationships apply (within certain limits) both to the sensitization itself and to the exacerbation of the diseases. This suggest that exposure reduction may be one of the methods for reduction of risk, in relation to control of the allergic airway diseases.
引用
收藏
页码:231 / 242
页数:12
相关论文
共 88 条
[1]  
Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434
[2]   NORDPET -: Pets indoors -: A risk factor for or protection against sensitisation/allergy -: A Nordic interdisciplinary review of the scientific literature concerning the relationship between the exposure to pets at home, sensitisation and the development of allergy [J].
Ahlbom, A ;
Backman, A ;
Bakke, J ;
Foucard, T ;
Halken, S ;
Kjellman, NIM ;
Malm, L ;
Skerfving, S ;
Sundell, J ;
Zetterström, O .
INDOOR AIR, 1998, 8 (04) :219-235
[3]   Worsening of asthma in children allergic to cats, after indirect exposure to cat at school [J].
Almqvist, C ;
Wickman, M ;
Perfetti, L ;
Berglind, N ;
Renström, A ;
Hedrén, M ;
Larsson, K ;
Hedlin, G ;
Malmberg, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2001, 163 (03) :694-698
[4]   Inflammatory cell and epithelial characteristics of perennial allergic and nonallergic rhinitis with a symptom history of 1 to 3 years' duration [J].
Amin, K ;
Rinne, J ;
Haahtela, T ;
Simola, M ;
Peterson, CGB ;
Roomans, GM ;
Malmberg, H ;
Venge, P ;
Sevéus, L .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) :249-257
[5]   Incidence and outcomes of asthma in the elderly - A population-based study in Rochester, Minnesota [J].
Bauer, BA ;
Reed, CE ;
Yunginger, JW ;
Wollan, PC ;
Silverstein, MD .
CHEST, 1997, 111 (02) :303-310
[6]   Prevalence and etiology of asthma [J].
Beasley, R ;
Crane, J ;
Lai, CKW ;
Pearce, N .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (02) :S466-S472
[7]   HETEROGENEITY OF ATOPY .1. CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF PATIENTS ALLERGIC TO CYPRESS POLLEN [J].
BOUSQUET, J ;
KNANI, J ;
HEJJAOUI, A ;
FERRANDO, R ;
COUR, P ;
DHIVERT, H ;
MICHEL, FB .
ALLERGY, 1993, 48 (03) :183-188
[8]   Molecular and biochemical classification of plant-derived food allergens [J].
Breiteneder, H ;
Ebner, C .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 106 (01) :27-36
[9]   Allergy prevalence and causal factors in the domestic environment: results of a random population survey in the United Kingdom [J].
Brown, CW ;
Hawkins, L .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 83 (03) :240-244
[10]  
Burr ML, 1999, CLIN EXP ALLERGY, V29, P735